Professor and Vice-Chair
Department of Pharmacology and Chemical Biology;
Director of Education
Women’s Cancer Research Center;
Co-Leader, Cancer Biology Program
University of Pittsburgh Medical Center
Hillman Cancer Center
Pittsburgh, Pennsylvania
For trailblazing research in invasive lobular carcinoma (ILC) that redefined it as a distinct biological entity, transforming its diagnosis and treatment. Her work has illuminated differences in nuclear receptor activity, metastatic patterns, metabolism, and immune modulation between ILC and invasive ductal carcinoma, laying the foundation for novel therapeutic strategies. Dr. Oesterreich’s discoveries in estrogen receptor biology, endocrine resistance, and tumor metastasis have advanced precision medicine approaches, impacting both fundamental cancer science and patient care.
The AACR established the AACR Distinguished Lectureship in Breast Cancer Research, which is generously supported by Aflac, Inc., to recognize outstanding science that has inspired, or has the potential to inspire, new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer. To learn more, please visit the press release.
View Past Recipients.